OCRS, DECAF, and BAP-65 scores for predicting the outcomes of acute COPD exacerbation: A prognostic accuracy study
Journal of Emergency Practice and Trauma · 18.12.2025 · 10 (2) · 118-127
DOI: 10.34172/jept.2025.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Emergency Practice and Trauma, online erschienen am 31.08.2025. Verfasst von Ali Mohammad Rousta und 3 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
Objective
Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a significant healthcare burden. This study aimed to compare three risk assessment tools in predicting the outcomes of COPD exacerbation.
Methods
This prospective cohort study was conducted between October 2023 and November 2024 at five hospitals in Iran (three in Tehran, one in Shahr-e-Rey, and one in Nehbandan). A total of 392 patients admitted with acute exacerbation of COPD were enrolled using consecutive sampling. The predictive accuracy of the Ottawa COPD Risk Scale (OCRS), DECAF, and BAP-65 for adverse outcomes (ICU admission, mechanical ventilation, and mortality) was assessed. The area under the receiver operating characteristic curve (AUC-ROC) and performance metrics (sensitivity, specificity, predictive values, and likelihood ratios) were calculated for each score. AUCs were compared using paired sample ROC analysis with significance set at P < 0.05.
Results
The AUCs for OCRS, DECAF, and BAP-65 in predicting cumulative adverse outcomes (CAO) were 0.78 (95% CI: 0.73–0.83), 0.79 (95% CI: 0.74–0.83), and 0.79 (95% CI: 0.74–0.83), respectively (P < 0.05). For CAO, DECAF and BAP-65 demonstrated the most balanced performance at optimal cutoff, with sensitivities of 69.8% (95% CI: 61.9–75.4) and 68.2% (95% CI: 59.7–75.6) and specificities of 78.7% (95% CI: 0.74.5–0.81.8) and 78% (95% CI: 72.5–82.5). OCRS had a sensitivity of 61.2% (95% CI: 52.6–0.77) and a specificity of 84.8% (95% CI: 80.3–89.5). No significant confounding or effect modifications from demographics, lifestyle factors, or comorbidities were found except for age with DECAF, which performed better in younger patients.
Conclusion
DECAF and BAP-65 showed the most balanced performances in predicting CAO amongst the three tools. Paired with a clinician’s judgment, these tools offer valuable insights for better triage and clinical decision-making in managing acute COPD exacerbation.
Zitieren
APA
Rousta, A. M., Safari, S., Ranjbar, M. F., & Aghili, S. H. (2025). OCRS, DECAF, and BAP-65 scores for predicting the outcomes of acute COPD exacerbation: A prognostic accuracy study. Journal of Emergency Practice and Trauma, 10(2), 118-127. https://doi.org/10.34172/jept.2025.16
Vancouver
Rousta AM, Safari S, Ranjbar MF, Aghili SH. OCRS, DECAF, and BAP-65 scores for predicting the outcomes of acute COPD exacerbation: A prognostic accuracy study. Journal of Emergency Practice and Trauma. 2025;10(2):118-127. doi:10.34172/jept.2025.16
BibTeX
@article{Rousta2025,
author = {Rousta, Ali Mohammad and Safari, Saeed and Ranjbar, Mehri Farhang and Aghili, Seyed Hadi},
title = {OCRS, DECAF, and BAP-65 scores for predicting the outcomes of acute COPD exacerbation: A prognostic accuracy study},
journal = {Journal of Emergency Practice and Trauma},
year = {2025},
volume = {10},
number = {2},
pages = {118--127},
doi = {10.34172/jept.2025.16}
}
EUVIMED